Alnylam Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2830 www.alnylam.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress - Feb 12th, 2026 6:00 am
Halozyme Therapeutics (HALO) to Report Q4 Results: Wall Street Expects Earnings Growth - Feb 10th, 2026 8:00 am
Countdown to Alnylam (ALNY) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Feb 9th, 2026 7:15 am
Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet? - Feb 9th, 2026 4:00 am
Do Options Traders Know Something About Alnylam Pharmaceuticals Stock We Don't? - Feb 6th, 2026 6:34 am
3 Stocks Estimated To Be Trading At Discounts Of Up To 49.2% - Feb 5th, 2026 10:39 am
Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy? - Feb 5th, 2026 8:00 am
Discounted Value Stocks With Estimated Upside In February 2026 - Feb 5th, 2026 4:38 am
3 Stocks Estimated To Be Trading At Discounts Up To 44% - Feb 4th, 2026 10:38 am
Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 49% Undervaluation? - Feb 4th, 2026 5:00 am
Discover 3 Stocks Possibly Trading At Discounts Of Up To 49.6% - Feb 4th, 2026 4:38 am
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth - Jan 31st, 2026 7:35 am
Alnylam Pharmaceuticals (ALNY) Valuation Check After Recent Share Price Weakness - Jan 31st, 2026 2:15 am
Phillip Allen Sharp Improved Human Health With Breakthroughs - Jan 29th, 2026 2:09 pm
Alnylam Pharmaceuticals Projects 2026 Revenue Around $5.3 Billion as It Focuses on a New Five-Year Strategy - Jan 29th, 2026 12:27 pm
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results - Jan 29th, 2026 6:00 am
Should You Buy Alnylam Pharmaceuticals Before Feb. 12? - Jan 28th, 2026 3:04 am
Wells Fargo Raises Alnylam (ALNY) Revenue Estimates for Amvuttra Despite Projected Margin Compression - Jan 27th, 2026 6:38 am
Is It Time To Reassess Alnylam (ALNY) After Recent Share Price Pullback? - Jan 14th, 2026 7:07 am
JPM26: 2025 a “breakout year” for rare disease biotechs - Jan 14th, 2026 6:02 am